Invesaro

Stocks Consumer staples SHFH

OTC · Consumer staples

Scientist Home Future Health Ltd (SHFH)

Scientist Home Future Health Ltd brought in $399.3K of revenue over the twelve months to June 30, 2026. It posted a net loss of $400.5K. In fiscal 2025 capital spending exceeded operating cash flow by $323.1K. At June 30, 2026 it held $9K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 11, 2026.

Free, no password. An email when SHFH files with the SEC.

Price
$1.70
0.00% on the day · October 22, 2026
52-week range $1.70 to $12.00
Market cap
$40.3M
Revenue (last 12 months)
$399.3K
Net margin
-100.3%

Key facts about Scientist Home Future Health Ltd

Net worth
Scientist Home Future Health Ltd has a market value (market cap) of $40.3M at the latest share price, and shareholders' equity of -$86.3K on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $204.1K, with a net loss of $231.7K. Over the 12 months to June 30, 2026: revenue $399.3K, net loss $400.5K.
Cash flow
In fiscal 2025 operations used $248.3K of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 11, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Scientist Home Future Health Ltd's next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What Scientist Home Future Health Ltd does

Scientist Home Future Health Ltd is registered with the SEC under industry code SIC 2844 (Perfumes, Cosmetics & Other Toilet Preparations). Its shares trade on OTC under the ticker SHFH.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$204.1K-$231.7K-$231.7K-$0.01-$323.1K

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around November 11, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 12, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where SHFH ranks in Consumer staples

Revenue$204.1K
#151 of 160 in Consumer staples · Bottom 6%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Consumer staples

Latest SEC filings

What Scientist Home Future Health Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 11, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 163% to $82.9K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
  2. May 14, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue rose 321% to $188.8K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
  3. March 27, 2026
    Annual report 10-K · period to December 31, 2025Revenue was $204.1K; diluted EPS was -$0.01.
  4. November 12, 2025
    Quarterly report 10-Q · period to September 30, 2025Revenue fell 33% to $39.6K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
  5. August 12, 2025
    Quarterly report 10-Q · period to June 30, 2025Revenue was $31.6K; diluted EPS was $0.00.
  6. May 15, 2025
    Quarterly report 10-Q · period to March 31, 2025Revenue was $44.8K; diluted EPS was $0.00.
  7. April 16, 2025
  8. March 27, 2025
  9. March 6, 2025
  10. January 16, 2025

Insider trades

What the people running Scientist Home Future Health Ltd did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about SHFH

What does Scientist Home Future Health Ltd do?

Scientist Home Future Health Ltd is a company in the Consumer staples sector, listed on OTC as SHFH. Its shares trade on OTC under the ticker SHFH.

What is Scientist Home Future Health Ltd's net worth?

Scientist Home Future Health Ltd has a market value (market cap) of $40.3M at the latest share price, and shareholders' equity of -$86.3K on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Scientist Home Future Health Ltd profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $400.5K on revenue of $399.3K.

How much revenue does Scientist Home Future Health Ltd make?

Over the twelve months to June 30, 2026 Scientist Home Future Health Ltd reported revenue of $399.3K.

When did Scientist Home Future Health Ltd last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 11, 2026. It covers the period to June 30, 2026.

When is Scientist Home Future Health Ltd's next earnings report?

Scientist Home Future Health Ltd's next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare SHFH with

Compare SHFH with any company

Follow SHFH

Get an email when Scientist Home Future Health Ltd files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when SHFH files with the SEC.

Where the numbers come from

Financial figures are the values Scientist Home Future Health Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.